Lilly Seeks Emergency Use Of Its Antibody Drug For COVID-19


A drug company says it has asked the U.S. government to allow emergency use of an experimental antibody therapy based on early results from a study that suggested the drug reduced symptoms, the amount of virus, hospitalizations and ER visits for patients with mild or moderate COVID-19.

Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists. Its drug is similar to one that President Donald Trump received on Friday from a different company.

These medicines supply concentrated versions of specific antibodies to help the immune system clear the coronavirus that causes COVID-19.

Rock And Roll Hall Of Fame Mourns Eddie Van Halen

Previous article

Russia Reports Successful Test Launch Of Hypersonic Missile

Next article

You may also like